Rankings · Growth
Fastest-growing A-graded companies
Graded A, with more than $1B of revenue now and at least $250M three years ago, ranked by how fast revenue grew each year over those three years — the same comparison the grade’s own “revenue growing overall” check makes.
65 companies meet this test
Figures as of October 1, 2026
| # | Company | Grade | Revenue growth | Free cash flow growth | Net margin | Market value |
|---|---|---|---|---|---|---|
| 1 | NVSNovartis AG | A | +70% a year | +10% a year | -0.1% | $278B |
| 2 | HIMSHIMS & HERS HEALTH, INC. | A- | +54% a year | — | -5.5% | $6.6B |
| 3 | ALNYALNYLAM PHARMACEUTICALS, INC. | A+ | +53% a year | — | 19.7% | $34B |
| 4 | ONCBEONE MEDICINES LTD. | A+ | +50% a year | — | 10.7% | $41.6B |
| 5 | OSCROscar Health, Inc. | A | +46% a year | +206% a year | 3.6% | $9.9B |
| 6 | GMEDGLOBUS MEDICAL, INC. | A+ | +42% a year | +84% a year | 17.0% | $10.2B |
| 7 | ALHCALIGNMENT HEALTHCARE, INC. | A | +41% a year | — | 0.9% | $1.6B |
| 8 | LLYELI LILLY AND COMPANY | A+ | +39% a year | +70% a year | 33.5% | $1.12T |
| 9 | PACSPACS Group, Inc. | A | +32% a year | — | 4.8% | $6.7B |
| 10 | HALOHALOZYME THERAPEUTICS, INC. | A+ | +29% a year | +40% a year | 24.9% | $12.7B |
| 11 | ACADACADIA PHARMACEUTICALS INC. | A+ | +27% a year | — | 33.4% | $3.5B |
| 12 | NBIXNEUROCRINE BIOSCIENCES INC | A+ | +26% a year | +46% a year | 20.9% | $14.1B |
| 13 | BTSGBrightSpring Health Services, Inc. | A | +23% a year | — | 2.5% | $11B |
| 14 | MEDPMedpace Holdings, Inc. | A+ | +18% a year | +24% a year | 17.7% | $17.4B |
| 15 | ISRGIntuitive Surgical, Inc. | A+ | +18% a year | +40% a year | 28.4% | $145.6B |
| 16 | LFSTLifeStance Health Group, Inc. | A | +18% a year | — | 3.2% | $4.5B |
| 17 | PENPenumbra, Inc | A | +17% a year | — | 10.7% | $12.6B |
| 18 | GMABGenmab A/S | A+ | +16% a year | +4% a year | 25.9% | $2.2B |
| 19 | DXCMDEXCOM, INC. | A+ | +16% a year | +44% a year | 20.1% | $32.7B |
| 20 | EWEdwards Lifesciences Corporation | A+ | +15% a year | +27% a year | 15.4% | $50.8B |
| 21 | BMRNBIOMARIN PHARMACEUTICAL INC | A | +15% a year | — | 2.1% | $11.6B |
| 22 | ADUSAddus HomeCare Corp | A | +14% a year | — | 7.1% | $2.1B |
| 23 | HQYHEALTHEQUITY, INC. | A+ | +13% a year | +32% a year | 17.4% | $7.2B |
| 24 | MCKMcKESSON CORPORATION | A | +13% a year | +11% a year | 1.1% | $100.9B |
| 25 | AMGNAmgen Inc. | A+ | +13% a year | +2% a year | 23.0% | $229B |
More rankings
A ranking orders companies by one stated measure. It is not a recommendation, and it says nothing about whether any share price is reasonable.